Multi-Immunogenic Outer Membrane Vesicles Derived from a MsbB-Deficient Salmonella enterica Serovar Typhimurium Mutant |
Lee, Sang-Rae
(The National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB))
Kim, Sang-Hyun (The National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB)) Jeong, Kang-Jin (The National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB)) Kim, Keun-Su (The National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB)) Kim, Young-Hyun (The National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB)) Kim, Sung-Jin (The National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB)) Kim, E-Kyune (The National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB)) Kim, Jung-Woo (Department of Animal Resources and Science, Dankook University) Chang, Kyu-Tae (The National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB)) |
1 | Alaniz, R. C., B. L. Deatherage, J. C. Lara, and B. T. Cookson. 2007. Membrane vesicles are immunogenic facsimiles of Salmonella Typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J. Immunol. 179: 7692-7701 |
2 | Beveridge, T. J. 1999. Structures of Gram-negative cell walls and their derived membrane vesicles. J. Bacteriol. 181: 4725-4733 |
3 | Guzman, L., D. Belin, M. Carson, and J. Beckwith. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose promoter. J. Bacteriol. 177:4121-4130 |
4 | Henry, T., Stphanie. Pommier, L. Journet, A. Bernadac, J. P. Gorvel, and R. Lloubs. 2004. Improved methods for producing outer membrane vesicles in Gram-negative bacteria. Res. Microbiol. 155: 437-446 DOI ScienceOn |
5 | Liu, T., R. Knig, J. Sha, S. L. Agar, C. T. Tseng, G. R. Klimpel, and A. K. Chopra. 2008. Immunological responses against Salmonella enterica serovar Typhimurium Braun lipoprotein and lipid A mutant strains in Swiss-Webster mice: Potential use as live-attenuated vaccines. Microb. Pathog. 44:224-237 DOI ScienceOn |
6 | Serra-Moreno, R., S. Acosta, J. P. Hernalsteens, J. Jofre, and M. Muniesa. 2006. Use of the lambda Red recombinase system to produce recombinant prophages carrying antibiotic resistance genes. BMC Mol. Biol. 7: 1-12 DOI PUBMED ScienceOn |
7 | Vogel, H. and F. Jhnig. 1986. Models for the structure of outermembrane proteins of Escherichia coli derived from Raman spectroscopy and prediction methods. J. Mol. Biol. 190: 191-199 DOI PUBMED |
8 | Wang, L., J. A. Huang, H. S. Nagesha, S. C. Smith, A. Phelps, I. Holmes, J. C. Martyn, P. J. Coloe, and P. R. Reeves. 1999. Bacterial expression of the major antigenic regions of porcine rotavirus VP7 induces a neutralizing immune response in mice. Vaccine 17: 2636-2645 DOI ScienceOn |
9 | Zhou, Z., S. Lin, R. J. Cotter, and C. R. Raetz. 1999. Lipid A modifications characteristic of Salmonella typhimurium are induced by in Escherichia coli K12. J. Biol. Chem. 274: 18503-18514 DOI PUBMED |
10 | Schorr, J., B. Knapp, E. Hundt, H. A. Kupper, and E. Amann. 1991. Surface expression of malarial antigens in Salmonella Typhimurium: Induction of serum antibody response upon oral vaccination of mice. Vaccine 9: 675-681 DOI ScienceOn |
11 | Kuehn, M. J. and N. C. Kesty. 2005. Bacterial outer membrane vesicles and the host pathogen interaction. Genes Dev. 19:2645-2655 DOI ScienceOn |
12 | Kadurugamuwa, J. L. and T. J. Beveridge. 1997. Natural release of virulence factors in membrane vesicles by Pseudomonas aeruginosa and the effect of aminoglycoside antibiotics on their release. J. Antimicrob. Chemother. 40: 615-621 DOI ScienceOn |
13 | Hitchcock, P. J. and T. M. Brown. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154: 269-277 |
14 | Pratelli, A., A. Cavalli, V. Martella, M. Tempesta, N. Decaro, L. E. Carmichael, and C. Buonavoglia. 2001. Canine parvovirus (CPV) vaccination: Comparison of neutralizing antibody responses in pups after inoculation with CPV2 or CPV2b modified live virus vaccine. Clin. Diagn. Lab. Immunol. 8: 612-615 PUBMED ScienceOn |
15 | Datsenko, K. A. and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U.S.A. 97: 6640-6645 DOI ScienceOn |
16 | Mo, E., S. E. Peters, C. Willers, D. J. Maskell, and I. G. Charles. 2006. Single, double and triple mutants of Salmonella enterica serovar Typhimurium degP (htrA), degQ (hhoA) and degS (hhoB) have diverse phenotypes on exposure to elevated temperature and their growth in vivo is attenuated to different extents. Microb. Pathog. 41: 174-182 DOI ScienceOn |
17 | Patial, S., V. K. Chaturvedi, A. Rai, M. Saini, R. Chandra, Y. Saini, and P. K. Gupta. 2007. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2. Vaccine 25: 4020-4028 DOI ScienceOn |
18 | Low, K. B., M. Ittensohn, T. Le, J. Platt, S. Sodi, M. Amoss, et al. 1999. Lipid A mutant Salmonella with suppressed virulence and TNF-alpha induction retain tumor-targeting in vivo. Nat. Biotechnol. 17: 37-41 DOI PUBMED ScienceOn |
19 | Smith, A. E., S. H. Kim, F. Liu, W. Jia, E. Vinogradov, C. L. Gyles, and R. E. Bishop. 2008. PagP activation in the outer membrane triggers R3 core oligosaccharide truncation in the cytoplasm of Escherichia coli O157:H7. J. Biol. Chem. 283:4332-4343 PUBMED |
20 | Borrow, R., I. S. Aaberge, G. F. Santos, T. L. Endey, P. Oster, A. Glennie, et al. 2005. Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine. Clin. Diagn. Lab. Immunol. 12: 970-976 PUBMED ScienceOn |
21 | Park, J. S., B. K. Choi, L. S. Vijayachandran, V. Ayyappan, C. K. Chong, K. S. Lee, S. C. Kim, and C. W. Choi. 2007. Immunodetection of canine parvovirus (CPV) in clinical samples by polyclonal antisera against CPV-VP2 protein expressed in Escherichia coli as an antigen. J. Virol. Methods 146: 281-287 DOI ScienceOn |
22 | Martin, D., L. McCallum, A. Glennie, N. Ruijne, P. Blatchford, J. O'Hallahan, and P. Oster. 2005. Validation of the serum bactericidal assay for measurement of functional antibodies against group B meningococci associated with vaccine trials. Vaccine 23: 2218-2221 DOI ScienceOn |
23 | Crdenas, L. and J. D. Clements. 1992. Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clin. Microbiol. Rev. 5: 328-342 PUBMED ScienceOn |
24 | Mastroeni, P., J. A. Chabalgoity, S. J. Dunstan, D. J. Maskell, and G. Dougan. 2001. Salmonella: Immune responses and vaccines. Vet. J. 161: 132-164 DOI ScienceOn |